• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

High Variability in ICU Transfusion Practices Globally

October 18, 2023

The International Point Prevalence Study of Intensive Care Unit Transfusion Practices (InPUT) is a prospective cohort study that included 3643 adult patients (62% male; mean age, 61 years) from 233 intensive care units (ICUs) (median of 11 patients per ICU) across six continents in 30 countries. The study was designed to assess global transfusion practices in the ICU.  In total, 25% (894/2643) of patients received at least one RBC transfusion in the ICU with a mean of two RBC units transfused per patient, which was similar to another worldwide study published over a decade ago.  The proportion of patients transfused ranged from 0% to 100% of patients across centers, from 0% to 80% across countries, and from 19% to 45% across continents.  Across all continents, a low hemoglobin level was the most common reason stated for RBC transfusion (82%; mean Hb before transfusion, 7.4 g/dL) followed by active bleeding (28%) and hemodynamic instability (24%).  Most transfusion events were also triggered by one or more physiological conditions (i.e., non-Hb)—most commonly hypotension, tachycardia, or increased lactate levels.  Overall, this study found considerable variation between individual centers, but the reasons for the variability require further inquiry.

References:

  1. Raasveld SJ, de Bruin S, Reuland MC, et al. Red Blood Cell Transfusion in the Intensive Care Unit. JAMA Published online October 12, 2023. 
  2. Neal MD, Hunt BJ. Precision in Transfusion Medicine. Published online October 12, 2023. 

Filed Under

  • Featured
  • News
  • RBC Transfusion

Recommended

  • New Draft Guidance Recommendations from the FDA to Reduce Risk of Transfusion-Transmitted Creutzfeldt-Jakob Diseases

  • Platelet-Rich Plasma Injections Do Not Reduce Tendon Dysfunction in Patients with Chronic Midportion Achilles Tendinopathy

  • Enzymatic Conversion of Group A Blood to Universal Group O Blood

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Acute Normovolemic Hemodilution Does Not Reduce RBC Transfusions

  • Blood Donation Teams—a Novel Strategy to Support Novice Donors

  • Plasma Exchange to Reduce Biological Age

  • New Guidelines for Platelet Transfusion Recommend Restrictive Strategies

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley